ADMA Biologics, Inc.
ADMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $36 | $34 | $27 | $112 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $5 | $2 | $0 | $0 |
| Stock-Based Comp. | $5 | $5 | $5 | $5 |
| Change in WC | -$37 | -$23 | -$57 | $10 |
| Other Non-Cash | $2 | $1 | $4 | -$79 |
| Operating Cash Flow | $13 | $21 | -$20 | $50 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$2 | -$5 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | -$0 | -$0 | $0 |
| Investing Cash Flow | -$14 | -$3 | -$5 | -$3 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3 | -$0 | $0 | -$30 |
| Stock Issued | $0 | $2 | $0 | $0 |
| Stock Repurch. | -$23 | $0 | -$7 | -$1 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$2 | $0 | -$0 |
| Financing Cash Flow | -$28 | $0 | -$7 | -$31 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$29 | $19 | -$32 | $16 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $90 | $72 | $103 | $87 |
| End Cash | $61 | $90 | $72 | $103 |
| Free Cash Flow | -$1 | $19 | -$24 | $47 |